1[1]Voger RA, Corretti MC, Poltnick GN et al. Changes in flow mediated brachial artey vasoactivity with lowering of desirable cholesterol levels in healthy middleaged men [J]. Am J Cardiol, 1996;77:37-40. 被引量：1
2[2]Laufs U, Fata VI, Plutzky J et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J]. Circulation, 1998;97:1129-1135. 被引量：1
3[3]Fuster V, Gotto AM, Libby P. 27th Bethesda conference: Matching the intenslty of risk factor management with the hazard for coronary disease event. Task Force 1, Pathogenesis of coronary disease: The biologic role of risk factors [J]. J Am Coll Cardiol, 1996; 27: 964-976. 被引量：1
4[4]Treasure CB, Klein JL, Weintraub WS. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery diseases [J]. N Engl J Med,1995;332:481-487. 被引量：1
6Corretti, Anderson T J, Benjamin ELI, et al. Guideline for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatinn of the braehial artery: a report of the International Braehial Artery Reactivity Task Force[J]. J Am Coil Cardiol, 2002, 39 (1):257-265. 被引量：1
7Romano M, Pomilio M, Vigneri S,et al, Endothelial perturbation in children and adolescents with type 1 diabetes: association with mar kers of the inflammatory reaction [J]. Diabetes Care, 2001,24(9) : 1674. 被引量：1
8Hayaishi-Okano R, Yamasaki Y, Katakami N,et al. Elevated Creactive protein associates with early stage carotid atherosclerosis in young subjects with type 1 diabetes[J]. Diabetes Care,2002,25(7): 1432-1438. 被引量：1
9Fichtlscherer S, Rosenberger G, Walter DH,et al. Elevated Creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].Circulation,2000,102 (4): 1000-1006. 被引量：1
10Bhagat K, Valance E Inflammatory cytokincs impair cndothclium dependent dilatation in human veins in vivo[J]. Circulation, 1997,96 (12): 3042-3047. 被引量：1
